6,678 trials
Asthma, Aspirin-Induced · Chronic Rhinosinusitis With Nasal Polyps
Primary: Change From Baseline at Week 16 in Sinonasal Outcome Test -22 (SNOT-22) Score — -14.09; -4.37 points
High Altitude
Primary: Rate of Exogenous Glucose Oxidation — 0.31; 0.32 g/min
Mood Disturbance · Mood Disorders · Natural Supplements
Primary: Mean Change in the Parent-Young Mania Rating Scale (P-YMRS) Score — -2.4; -1.9 Units on YMRS Scale
Abortion, Second Trimester · PPROM · Rupture, Spontaneous
Primary: Delivery Within 12 Hours — 5; 5 Participants
Depression · Anhedonia
Primary: Montgomery-Asberg Depression Rating Scale (MADRS) Score — 28.9; 24.9; 21.4; 20.7 score on a scale — p=<0.001
Nausea and Vomiting, Postoperative · Cesarean Section Complications
Primary: Medications Received — 0.23; 0.40 Medications
Primary Hemophagocytic Lymphohistiocytosis
Primary: Permanent Discontinuation of Study Drug Due to Emapalumab-related Adverse Event — 0 Participants
Lower Urinary Tract Symptoms
Primary: Bladder Capacity — 363; 402 milliliters
Antibiotic Enterocolitis
Primary: Change in Mean Number of Colonic Submucosal Neurons/mm^2 in the Colon After Antibiotic Treatment — 0 neuronal cells/mm^2
Post-ERCP Acute Pancreatitis
Primary: Post-ERCP Pancreatitis — 15; 21 Participants
Bowel Preparation Before Colonoscopy
Primary: Number of Participants With Adequate Bowel Preparation — 111; 111 Participants — p=0.007
Coronary Arterial Disease (CAD)
Primary: 888 Number of Participants With Major Adverse Cardiac Events (MACE) at 30 Days — 0 participants
Dietary Supplements
Primary: Adjusted Mean Change From Baseline in Multidimensional Fatigue Inventory (MFI) General Fatigue Domain Score at Week 12 — -5.23; -5.48 score on a scale — p=0.5472
Attention-Deficit/Hyperactivity Disorder
Primary: Change From Baseline in the Adult ADHD Investigator Symptom Rating Scale (AISRS) Total Score by Visit. — 37.5; -12.3; -14.3; -17.3 score on a scale
Pediatric HD · Bleeding
Primary: A Composite of the Number of Any Allogeneic Blood Products (RBCs, Plasma, Platelets, Cryoprecipitate) Transfused From Administration of the Study Medication Until 48…